Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

Código QR

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

Guardado en:

Detalles Bibliográficos
Autores principales:	Guru Sonpavde, Na Li, Zheng Zhu, Fan Cheng, Shaoming Zhu, A-Hong Ma, Elio Adib, Ting Rao, Kaiyuan Ni, Veera Chandra Sekhar Reddy Chittepu, Rao Prabhala, Juan Garisto Risco, David Kwiatkowski, Kent Mouw, Chong-xian Pan
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/934d422d19464781b6e424dfea9fbd98
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies
por: Wenwen Yang, et al.
Publicado: (2021)

Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
por: Chi Yan, et al.
Publicado: (2021)

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
por: Alessandra Lopes, et al.
Publicado: (2018)

Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
por: Kaiyuan Ni, et al.
Publicado: (2018)

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
por: Yong Liang, et al.
Publicado: (2018)

Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
por: Shahram Salek-Ardakani, et al.
Publicado: (2021)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
por: A. V. Bogolyubova, et al.
Publicado: (2015)

Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy
por: Zhao P, et al.
Publicado: (2021)

Metabolomic adaptations and correlates of survival to immune checkpoint blockade
por: Haoxin Li, et al.
Publicado: (2019)

Predictors of responses to immune checkpoint blockade in advanced melanoma
por: N. Jacquelot, et al.
Publicado: (2017)

Resistance to checkpoint blockade therapy through inactivation of antigen presentation
por: Moshe Sade-Feldman, et al.
Publicado: (2017)

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Katrin Aslan, et al.
Publicado: (2020)

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
por: Ju Yeon Lee, et al.
Publicado: (2016)

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
por: Jun Zhao, et al.
Publicado: (2019)

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
por: Pei-Yi Chu, et al.
Publicado: (2021)

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
por: Lin X, et al.
Publicado: (2021)

Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
por: Xiaopin Duan, et al.
Publicado: (2019)

NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy
por: Sayuri Yoshihama, et al.
Publicado: (2021)

Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
por: Frank Riemer, et al.
Publicado: (2021)

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
por: James Harber, et al.
Publicado: (2021)

Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
por: Marine Leclerc, et al.
Publicado: (2019)

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
por: Krista Dubin, et al.
Publicado: (2016)

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
por: Shohei Koyama, et al.
Publicado: (2016)

Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
por: Qian Chen, et al.
Publicado: (2016)

Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications
por: Hannah-Lou Schilling, et al.
Publicado: (2021)

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
por: Xiaoguang Li, et al.
Publicado: (2019)

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
por: Johannes Griss, et al.
Publicado: (2019)

Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis
por: James A. Hutchinson, et al.
Publicado: (2021)

In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
por: In-San Kim, et al.
Publicado: (2021)

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
por: Manisha Singh, et al.
Publicado: (2017)

Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
por: Dobrin Draganov, et al.
Publicado: (2021)

Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy
por: Antonella Cardinale, et al.
Publicado: (2021)

Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade
por: Kim M. Kraus, et al.
Publicado: (2021)

Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
por: Anna Morena D’Alise, et al.
Publicado: (2019)

Correction: In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
Publicado: (2021)

Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
por: Luuk van Hooren, et al.
Publicado: (2021)

Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade
por: Zia Khan, et al.
Publicado: (2021)

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
por: Qi Peng, et al.
Publicado: (2020)

Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice
por: Wenwen Yue, et al.
Publicado: (2019)

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
por: Robert A. Szczepaniak Sloane, et al.
Publicado: (2021)